Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixaprost versus Ganfort P in open-angle glaucoma or ocular hypertension
2020-000438-16Phase 4Active
- Sponsor
- Laboratoires Théa
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in open-angle glaucoma (OAG) and ocular hypertension comparing Fixaprost with Ganfort P (2 arms). Primary endpoint: Conjunctival hyperemia grade and score after 1 month. Started Jul 2020; status: active.
02
Drugs
Fixalpostbimatoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2020-000438-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000438-16.